ARCHIVES

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

This article is from The Cancer Letter archive.

Vol. 04 No. 41 | October 13, 1978

Download PDF Visit The Full Archive

Related Articles

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

February 23, 1979

NIH To Give 3 Percent Increase to Grants

March 20, 2009

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

January 15, 1999

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014